Company intelligence / Profile preview

Shell BioTech

Hangzhou, Zhejiang, China

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Hangzhou Shell Bio-Tech Co., Ltd. is a high-tech enterprise specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) products. Based in Hangzhou, China, the company focuses on rapid diagnostic test kits utilizing lateral flow immunoassay technology. Their product portfolio covers a wide range of applications, including fertility testing, infectious disease screening, drugs of abuse testing, and tumor marker detection. Shell Bio-Tech provides both branded products and OEM/ODM services to global markets, maintaining international quality standards such as ISO 13485 and CE certification.

Therapeutic areas: Women's HealthPsychiatryInfectious Diseases
Modalities: Device
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Shell BioTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shell BioTech.

Explore the full profile